Allopurinol 투여 후 발생한 심한 약물 이상 반응 13예의 임상적 고찰

참고문헌 (34)

1. "Studies with the experimental antitumor agent 4-amino pyrazolo", pp.4 482~9
2. "Allopurinol, erythema multiforme, and renal insufficiency", 312, pp.173~174 (1996)
3. "Comprehensive hospital drug monitoring (CHDM)", 52, pp.388~393 (1997)
4. "Drug-induced pseudolymphoma and drug hypersensivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)", 15, pp.250~257 (1996)
5. "Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia", 331, pp.623~634 (2005)
6. "Severe adverse cutaneous reactions to drugs", pp.1272~85
7. "granulocytic leukopenia as a prognostic indicator", pp.721~6
8. "association with thiazides and prior renal compromise", pp.553~8
9. "Allergic reaction to allopurinol with cross-reactivity to oxypurinol", (lph k), pp.333~5
10. "Description and guidelines for prevention in patients with renal insufficiency", pp.47~56
11. "Plasma oxypurinol concentration in a patient with allopurinol hypersensitivity", pp.842~6
12. "Relation between adverse events associated with allopurinol and renal function in patients with gout", 60, pp.981~983 (2001)
13. "Systemic hypersensitivity to allopurinol with acute interstitial nephritis", pp.105~9
14. "Allopurinol hypersensitivity in a patient with severe", pp.707~9
15. "Reactive metabolites and adverse drug reactions", 24, pp.229~238 (2003)
16. "Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome", 137, pp.605~608
17. "Is a drug alone sufficient to cause the drug hypersensitivity syndrome?", 140, pp.226~230 (2004)
18. "Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome", 83, pp.128~131 (2003)
19. "Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia", 40, pp.331~335 (2001)
20. "Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection", 148, pp.1032~1034 (2003)
21. "Human herpesvirus 6 and drug allergy", pp.255~260 (2003)
22. "HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol", 102, pp.4134~4139 (2005)
23. "Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome", 6, pp.543~539 (2006)
24. "Nevirapine-induced toxic epidermal necrolysis and toxic hepatitis treated successfully with a combination of intravenous immunoglobulins and N-acetylcysteine", 15, pp.255~258 (2004)
25. "Successful desensitization for treatment of an exfoliative dermatitis to allopurinol", 19, pp.980~984 (1999)
26. "Three cases of allopurinol hypersensitivity syndrome", 33, pp.130~134 (1995)
27. "A case of allopurinol hypersensitivity syndrome", 41, pp.251~254 (2003)
28. "A case of allopurinol hypersensitivity syndrome", 15, pp.107~109 (2003)
29. "Two cases of allopurinol hypersensitivity syndrome due to use of allopurinol for the patient with asymptomatic hyperuricemia", 43, pp.961~964 (2005)
30. "Two cases of allopurinol hypersensitivity syndrome", 43, pp.114~117 (2005)
31. "5 cases of allopurinol hypersensitivity syndrome", 26, pp.83~88 (2006)
32. "Asymptomatic hyperuricemia", 69, pp.594~ (2002), 597,600-2
33. "Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort", 44, pp.642~650 (2004)
34. "Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level", 47, pp.51~59 (2006)

관련 논문AI추천